Ads
related to: darzalex multiple myeloma- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- About DARZALEX®
Learn About a Treatment Method and
How DARZALEX® Works
- Questions for Your Doctor
Find a List Of Questions for You to
Ask Your Healthcare Provider
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- Preparing For Treatment
Watch a Video About What to Expect
Before, During, & After Treatment
- Important Safety Info
Learn About Important Safety
Information for DARZALEX®
- DARZALEX® Side Effects
Search results
Blood cancer multiple myeloma, once a death sentence, is now highly treatable. Here's why
USA TODAY via Yahoo News· 9 months agoAfter Judith Harding was diagnosed with multiple myeloma in 2009, she decided to retire, sold her...
How Triple-Refractory Multiple Myeloma Is Treated
Verywell Health via Yahoo News· 2 years agoTriple refractory multiple myeloma usually requires the use of two or more different kinds of drugs to improve survival outcomes and quality of life....
J&J sees mixed performance from new multiple myeloma drugs
BioPharma Dive via Yahoo Finance· 1 month agoTecvayli sales, which J&J broke out for the first time, surpassed Wall Street forecasts and offset...
Genmab: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 3 months agoGenmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple...
Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters via Yahoo Finance· 10 months agoInjectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster...
J&J's (JNJ) Q4 Earnings Beat, Darzalex, Stelara Drive Sales
Zacks via Yahoo Finance· 4 months agoJohnson & Johnson’s JNJ fourth-quarter 2023 earnings came in at $2.29 per share, which beat the...
EMA recommends earlier use of Bristol Myers cell therapy for multiple myeloma
BioPharma Dive via Yahoo Finance· 4 months agoThe opinion would allow Abecma to be prescribed after two standard therapies and is the latest sign...
HC Wainwright Is Bullish On This Multiple Myeloma Focused Stock
Benzinga via Yahoo Finance· 2 years agoHC Wainwright increased the price target on Genmab A/S (NASDAQ: GMAB) from $49 to $51, with a Buy...
This Cancer Drug Candidate Could Be a Hit for Pfizer
Motley Fool· 1 year agoLate last month, the U.S. Food and Drug Administration (FDA) granted priority review to Pfizer's (NYSE: PFE) multiple myeloma (MM) drug candidate...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 1 month agoJohnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...
Ad
related to: darzalex multiple myeloma
